These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37342206)

  • 1. Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy.
    Dai MG; Liu SY; Lu WF; Liang L; Ye B
    Clin Med Insights Oncol; 2023; 17():11795549231180351. PubMed ID: 37342206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit from adjuvant TACE combined with Lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy.
    Liang L; Xu ZD; Lu WF; Du CF; Gao ZY; Huang XK; Wang KD; Ye TW; Dai MG; Liu SY; Shen GL; Liu JW; Zhang CW; Huang DS
    Asian J Surg; 2024 May; ():. PubMed ID: 38724372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis.
    Danzeng A; Guo L; Yang ZH; He ZW; Zeng CL; Ciren P; Lan RH; Jiang XW; Wang C; Zhang BH
    J Gastrointest Surg; 2024 Jul; 28(7):1104-1112. PubMed ID: 38723996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus-related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection.
    Bai S; Hu L; Liu J; Sun M; Sun Y; Xue F
    Front Oncol; 2022; 12():919824. PubMed ID: 35898866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis.
    Ouyang J; Wang Z; Yuan K; Yang Y; Zhou Y; Li Q; Yang N; Zhao H; Zhao H; Zhou J
    J Hepatocell Carcinoma; 2023; 10():1465-1477. PubMed ID: 37701564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
    Kong J; Liang X; Zhang J; Zeng J; Liu J; Zeng J
    Dig Dis Sci; 2022 Aug; 67(8):4250-4257. PubMed ID: 34523084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.
    Wang L; Chen B; Li Z; Yao X; Liu M; Rong W; Wu F; Lin S; Liu Y; Zheng Y; Li Y; Wang W; Wu J
    Onco Targets Ther; 2019; 12():1237-1247. PubMed ID: 30863091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Dong W; Zou M; Sheng J; Zhou W; Wang Y; Zhang Y; Li J; Qian Y; Yu H; Lu T; Pan J; Zhu Y; Qu S; Yang Z; Lin Q; Zhao L; Cong W; Xu B; Zhang C; Liu H; Dong H
    J Gastrointest Oncol; 2023 Dec; 14(6):2479-2499. PubMed ID: 38196518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
    Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
    BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy.
    Feng LH; Zhu YY; Zhou JM; Wang M; Xu WQ; Zhang T; Mao AR; Cong WM; Dong H; Wang L
    Front Oncol; 2023; 13():1104492. PubMed ID: 37293583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion.
    Tao C; Zhang K; Tao Z; Liu Y; Wu A; Wang L; Feng Q; Wu F; Rong W; Wu J
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1928. PubMed ID: 37906430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.
    Zhang XP; Chai ZT; Gao YZ; Chen ZH; Wang K; Shi J; Guo WX; Zhou TF; Ding J; Cong WM; Xie D; Lau WY; Cheng SQ
    HPB (Oxford); 2019 Dec; 21(12):1687-1696. PubMed ID: 31153833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion.
    Qiu Y; Yang Y; Wang T; Shen S; Wang W
    Front Oncol; 2022; 12():831614. PubMed ID: 35795039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study.
    Cai J; Zhao J; Liu D; Xie H; Qi H; Ma J; Sun Z; Zhao H
    Front Oncol; 2021; 11():781029. PubMed ID: 34926296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.